Immunotherapy saves many lives – but could help even more people
One out of five patients with metastatic skin cancer can be cured with immunotherapy. But half of the patients with metastatic malignant melanoma are not helped by the new treatment. Researchers at the Sahlgrenska Cancer Center and on the Melanoma Team at Sahlgrenska University Hospital are working together in an attempt to understand why immunotherapy has such varied effects for different patients.
Area
Health and
medicine